I can see how people might have initially given Mr.
I can see how people might have initially given Mr. Bordynuik the benefit of the doubt, especially if they haven't had much experience with penny stocks. Most people in the world are honest, upright people--they say things and they keep their word. Why would anyone believe Mr. Bordynuik would be any different even if his claims were incredible??
However over time, Mr. Bordynuik has shown he is anything but. He's a despicable swindler and I don't think there's an honest bone in his body. The SEC bringing him up on accounting fraud charges and the corresponding published investigation should have alerted all shareholders to that fact. If not that then Mr. Bordynuik's lying about having an offer from Somerset Refinery after it was shut down or lying about commercial operations should have been enough for investors to take notice that he's not an honest person.
Mr. Heddle now has taken the reigns and has shown that ethics don't rank anywhere near his top ten priorities either. He literally announced that he would provide transparency and promised mid-quarter updates...and then let investors go on thinking for half a year that production was ramping up while the plant was kaput. Think about that for a minute.
You are invested in a scam stock. If you think about it you will realize why for six years you've never been told what exactly went into the processor at what cost and what exactly came out. You have no idea if there is any value added. Mr. Bordynuik's fantastical claims of $10/bbl cost and WTI-$3 sales were simply a fabrication made by a con man so he could extract dollars from anyone who believed him.
PTOI isn't the first scam stock in the pinks and it won't be the last. At least recognize that penny stock scams do exist and be more careful as you head off to invest in your next penny stock.
.
Plastic2Oil, Inc. (PTOI) Stock Research Links
Yes, I understand your penny stock also is the real deal, created with the inventiveness of Edison and destined to be the next Microsoft. Yes, I understand that the delays are also only because your company is making their product and/or technology even more revolutionary.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...
Continue Reading
Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...
Continue Reading
The air's thick with tension for investors of Blue Owl Technology Finance Corp. (NYSE:OTF) as they wake up to the news of a securities class action lawsuit that's no small fry. You don’t have to look too far to see why the folks holding the bag might be steamed. We’re talking about a 44% drop in stock price since the merger with Blue Owl Technology Finance Corp....
Continue Reading
Muyuan Foods Ready to Impress at EuroTier 2026 Let's face it, folks—when you think of game-changers in pig farming, Muyuan Foods Group deserves a nod. They're not just trotting out oinkers left and right; they're steering the whole paddock with innovations in smart pig farming and green development solutions. At EuroTier 2026 in Hanover, Muyuan’s booth—J04 in Hall...
Continue Reading
A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...
Continue Reading
Legal Storms Gather on Pinterest's Horizon I remember a time when Pinterest was the darling of Wall Street, but here we are, staring at an investigation that's got more layers than an onion. On November 6, 2026, news broke that Kahn Swick & Foti, LLC (KSF) is sniffing around Pinterest's officers and directors. This is no small fry since KSF is steered by none other than...
Continue Reading
Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...
Continue Reading
NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...
Continue Reading
Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...
Continue Reading
A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...
Continue Reading
Top 5 Most Recently Viewed Articles
Oncocyte Corporation snagged $10.2 million back in 2024 through a private placement, and let me tell ya, the chatter on the floor was intense. They’ve been making waves with their diagnostic tech, especially for organ transplant rejection testing, but was this funding enough to cover their gaps? That’s the question folks were tossing around. The Private Placement...
Continue Reading
Zoetis to Host Webcast for Q3 2024 Financial Results Zoetis Inc. (NYSE: ZTS) is gearing up for a live webcast and conference call at 8:30 a.m. (ET) on a Monday this November. This event will offer shareholders and investors an excellent chance to hear about Zoetis' financial performance for the third quarter of 2024. Joining the discussion will be Chief Executive Officer...
Continue Reading
Important Announcement Regarding the Extraordinary General Meeting SBM Offshore has officially published the agenda for the upcoming Extraordinary General Meeting of Shareholders (EGM) on its corporate website. This key event is scheduled to take place at the Sheraton Amsterdam Airport Hotel, an ideal venue highlighting the company’s commitment to facilitating...
Continue Reading
FNB Corporation's New Strategy Sparks Interest Ah, the ever-competitive world of financial services targets the well-heeled once again. FNB Corporation (NYSE: FNB), headquartered in Pittsburgh, is rolling up its sleeves to offer something new for ultra-high-net-worth clientele. Outside Wall Street's dizzying chaos, this quiet yet aggressive move seems to signal they're up...
Continue Reading
Upcoming Reverse Stock Splits for Virtus Funds HARTFORD, Conn. — The Virtus Convertible & Income Fund (NYSE: NCV) and the Virtus Convertible & Income Fund II (NYSE: NCZ) have announced a significant announcement for their shareholders. A 1-for-4 reverse stock split of the issued and outstanding shares for each fund will take effect as of the start of trading on Monday,...
Continue Reading
